Simon Li

Risk Control Director at Transcend VC & Grandway Capital (2017-11 – 2024-04)

Reporting directly to Managing Partner

Led due diligence for 40+ investment projects (deal sizes ¥3M-¥50M), interviewing company management, combining external due diligence reports, and conducting internal analysis. Negotiated investment agreements and completed transactions in technology, cross-border e-commerce, and consumer goods sectors.
Managed 10+ complex exits via secondary transfers and share buybacks (total transaction value ¥3B), leading negotiations for each deal, and facilitated IPO exits through pre-listing due diligence.
Managed the application for fund manager licenses and the regulatory filing of fund products with the Asset Management Association of China (AMAC). Handled investor relations, negotiated fund agreements, calculated fund performance metrics, prepared fundraising materials, and supported institutional investors throughout their investment decision-making process.
Oversaw post-investment monitoring of portfolio companies' financial and operational performance; ensured regulatory and investor disclosures; approved internal workflows; structured BVI SPVs and supported family trust setups for LPs.
Trusted by partners, portfolio founders, and institutional investors; contributed to exceptional fund performance with DPI > 4x and MOIC > 10x.

Senior Manager at Guosen Securities (2015-07 – 2017-08)

Developed timelines for IPO and NEEQ listings; formulated remediation plans addressing issues identified during due diligence; coordinated with lawyers, auditors, and other intermediaries to ensure efficient project execution.
Conducted financial, legal, and commercial due diligence; prepared and reviewed prospectuses and other critical disclosure documents.
Managed responses to regulatory inquiries by organizing intermediary teams to provide detailed replies and supplement evidentiary documentation, facilitating successful regulatory approvals.

Senior Associate at PwC (2012-09 – 2015-06)

Executed audit procedures for publicly listed companies, including interim reviews, walkthroughs, control testing, and year-end audits; prepared annual and interim financial reports.
Conducted internal control evaluations, interviewed client personnel, identified control deficiencies, and provided recommendations for remediation.
Key member of audit teams for China Ping An Life (601318.SH / 02318.HK), China Life AMC (601628.SH / 02628.HK), and CMB Cigna (601318.SH / 03968.HK); awarded "PwC Experience Recognise 2014 - Best Team (Mainland China / Hong Kong)".

關於